Target intelligence / Profile preview

Glycolysis pathway enzyme

Molecular classification
Enzyme
01

Overview

Glycolysis pathway enzymes are a group of cytoplasmic enzymes that catalyze the sequential conversion of glucose into pyruvate through ten distinct steps. These include hexokinase/glucokinase, phosphoglucoisomerase, phosphofructokinase, aldolase, triose phosphate isomerase, glyceraldehyde 3-phosphate dehydrogenase, phosphoglycerate kinase, phosphoglycerate mutase, enolase, and pyruvate kinase[1][7]. The process generates ATP and NADH for cellular energy needs. Three key regulatory enzymes—hexokinase/glucokinase (step 1), phosphofructokinase (step 3), and pyruvate kinase (step 10)—control the overall flux through the pathway[1][5]. Dysregulation or mutation in these enzymes can lead to diseases such as hemolytic anemia or contribute to cancer cell proliferation via the Warburg effect[4]. Because many tumors rely heavily on aerobic glycolysis for growth even under oxygen-rich conditions ("Warburg effect"), several glycolytic enzymes are considered promising therapeutic targets in oncology[4].

Other names
Glycolytic enzymeEnzyme of glycolysisGlycolytic pathway enzyme
02

Mechanism of action

Inhibition of enzymatic activity to block ATP production in cancer cells or pathogens Modulation of metabolic flux through the glycolytic pathway

03

Biological functions

Energy metabolismATP productionGlucose catabolismRedox balance
04

Disease associations

CancerHemolytic anemia (due to inherited enzyme deficiencies)Other metabolic disorders
05

Safety considerations

Systemic inhibition can impair normal cell energy supply, especially in tissues highly dependent on glycolysis such as red blood cells and brain.
06

Interacting drugs

2-Deoxyglucose (glycolysis inhibitor)

2 more in the full profile.

07

Biomarkers

Overexpression or increased activity of specific glycolytic enzymes as biomarkers for cancer diagnosis/prognosis (e.g., hexokinase II, pyruvate kinase M2 isoform)

Beyond the preview

Go deeper on Glycolysis pathway enzyme.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glycolysis pathway enzyme.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call